OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis
Ryosuke Oki, Yuishin Izumi, Koji Fujita, et al.
JAMA Neurology (2022) Vol. 79, Iss. 6, pp. 575-575
Open Access | Times Cited: 44
Ryosuke Oki, Yuishin Izumi, Koji Fujita, et al.
JAMA Neurology (2022) Vol. 79, Iss. 6, pp. 575-575
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
Stephen A. Johnson, Ton Fang, Fabiola De Marchi, et al.
Drugs (2022) Vol. 82, Iss. 13, pp. 1367-1388
Closed Access | Times Cited: 62
Stephen A. Johnson, Ton Fang, Fabiola De Marchi, et al.
Drugs (2022) Vol. 82, Iss. 13, pp. 1367-1388
Closed Access | Times Cited: 62
New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022
JingSi Jiang, Yan Wang, Min Deng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
JingSi Jiang, Yan Wang, Min Deng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis
Hristelina Ilieva, Mithila Vullaganti, Justin Kwan
BMJ (2023), pp. e075037-e075037
Open Access | Times Cited: 38
Hristelina Ilieva, Mithila Vullaganti, Justin Kwan
BMJ (2023), pp. e075037-e075037
Open Access | Times Cited: 38
Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series
Arsh Haj Mohamad Ebrahim Ketabforoush, Rojin Chegini, Shirin Barati, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114378-114378
Open Access | Times Cited: 34
Arsh Haj Mohamad Ebrahim Ketabforoush, Rojin Chegini, Shirin Barati, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114378-114378
Open Access | Times Cited: 34
Brain-Gut-Microbiota Axis in Amyotrophic Lateral Sclerosis: A Historical Overview and Future Directions
Shilan Chen, Xinhong Cai, Lin Lao, et al.
Aging and Disease (2024) Vol. 15, Iss. 1, pp. 74-74
Open Access | Times Cited: 12
Shilan Chen, Xinhong Cai, Lin Lao, et al.
Aging and Disease (2024) Vol. 15, Iss. 1, pp. 74-74
Open Access | Times Cited: 12
The Role of Gut Microbiota-derived Short Chain Fatty Acids in Amyotrophic Lateral Sclerosis
Mohamed J. Saadh, Shahad Mohammed Dhiaa, Pooja Bansal, et al.
Current Behavioral Neuroscience Reports (2025) Vol. 12, Iss. 1
Closed Access | Times Cited: 1
Mohamed J. Saadh, Shahad Mohammed Dhiaa, Pooja Bansal, et al.
Current Behavioral Neuroscience Reports (2025) Vol. 12, Iss. 1
Closed Access | Times Cited: 1
Advances in the early diagnosis of amyotrophic lateral sclerosis
Pilar H. García‐Casanova, Juan F. Vázquez‐Costa
Expert Review of Neurotherapeutics (2025)
Closed Access | Times Cited: 1
Pilar H. García‐Casanova, Juan F. Vázquez‐Costa
Expert Review of Neurotherapeutics (2025)
Closed Access | Times Cited: 1
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers
Jeremy M. Shefner, Richard Bedlack, Jinsy Andrews, et al.
JAMA Neurology (2022) Vol. 79, Iss. 12, pp. 1312-1312
Closed Access | Times Cited: 25
Jeremy M. Shefner, Richard Bedlack, Jinsy Andrews, et al.
JAMA Neurology (2022) Vol. 79, Iss. 12, pp. 1312-1312
Closed Access | Times Cited: 25
Vitamin B 12
Bruce H. R. Wolffenbuttel, P. Julian Owen, Mary Ward, et al.
BMJ (2023), pp. e071725-e071725
Open Access | Times Cited: 16
Bruce H. R. Wolffenbuttel, P. Julian Owen, Mary Ward, et al.
BMJ (2023), pp. e071725-e071725
Open Access | Times Cited: 16
Therapeutic targeting ofALS pathways: Refocusing an incomplete picture
Nicholas J. Maragakis, Mamede de Carvalho, Michael D. Weiss
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 1948-1971
Open Access | Times Cited: 15
Nicholas J. Maragakis, Mamede de Carvalho, Michael D. Weiss
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 1948-1971
Open Access | Times Cited: 15
Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS
Aven Lee, Robert D. Henderson, James Aylward, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1871-1871
Open Access | Times Cited: 5
Aven Lee, Robert D. Henderson, James Aylward, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1871-1871
Open Access | Times Cited: 5
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency
John V. Pluvinage, Thomas Ngo, Camille Fouassier, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Open Access | Times Cited: 5
John V. Pluvinage, Thomas Ngo, Camille Fouassier, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Open Access | Times Cited: 5
ALSFRS-R decline rate prior to baseline is not useful for stratifying subsequent progression of functional decline
Tatsuto Hamatani, Naoki Atsuta, Fumiya Sano, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2024) Vol. 25, Iss. 3-4, pp. 388-399
Open Access | Times Cited: 4
Tatsuto Hamatani, Naoki Atsuta, Fumiya Sano, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2024) Vol. 25, Iss. 3-4, pp. 388-399
Open Access | Times Cited: 4
Actively Protective Combinatorial Analysis: a Scalable Novel Method for Detecting Variants that Contribute to Reduced Disease Prevalence in High-Risk Individuals
Jason Sardell, Sayoni Das, Keith Taylor, et al.
Artificial Intelligence in the Life Sciences (2025) Vol. 7, pp. 100125-100125
Open Access
Jason Sardell, Sayoni Das, Keith Taylor, et al.
Artificial Intelligence in the Life Sciences (2025) Vol. 7, pp. 100125-100125
Open Access
Vitamins in the Prevention and Support Therapy of Neurodegenerative Diseases
Karolina Orywal, Katarzyna Socha, Piotr Iwaniuk, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1333-1333
Open Access
Karolina Orywal, Katarzyna Socha, Piotr Iwaniuk, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1333-1333
Open Access
Efficacy of Vitamin D Replacement Therapy on 28 Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After COVID-19 Vaccination
Shohta Kodama, Nafuko Konishi, Yuriko Hirai, et al.
Nutrition (2025) Vol. 134, pp. 112718-112718
Open Access
Shohta Kodama, Nafuko Konishi, Yuriko Hirai, et al.
Nutrition (2025) Vol. 134, pp. 112718-112718
Open Access
MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers
Eva P. Cuevas, Enrique López Madruga, Ignacio Valenzuela Martínez, et al.
Neurobiology of Disease (2025), pp. 106871-106871
Open Access
Eva P. Cuevas, Enrique López Madruga, Ignacio Valenzuela Martínez, et al.
Neurobiology of Disease (2025), pp. 106871-106871
Open Access
Early diagnosis of amyotrophic lateral sclerosis based on fasciculations in muscle ultrasonography: A machine learning approach
Koji Fukushima, Naoko Takamatsu, Yuki Yamamoto, et al.
Clinical Neurophysiology (2022) Vol. 140, pp. 136-144
Open Access | Times Cited: 16
Koji Fukushima, Naoko Takamatsu, Yuki Yamamoto, et al.
Clinical Neurophysiology (2022) Vol. 140, pp. 136-144
Open Access | Times Cited: 16
Microbiome and micronutrient in ALS: From novel mechanisms to new treatments
Jun Sun, Yongguo Zhang
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00441-e00441
Open Access | Times Cited: 3
Jun Sun, Yongguo Zhang
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00441-e00441
Open Access | Times Cited: 3
Specific vulnerability of iPSC-derived motor neurons with TDP-43 gene mutation to oxidative stress
Asako Onda-Ohto, Minami Hasegawa-Ogawa, Hiromasa Matsuno, et al.
Molecular Brain (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Asako Onda-Ohto, Minami Hasegawa-Ogawa, Hiromasa Matsuno, et al.
Molecular Brain (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Effects of motor cortical and peripheral axonal hyperexcitability on survival in amyotrophic lateral sclerosis
Ryo Otani, Kazumoto Shibuya, Yoichi Suzuki, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024) Vol. 95, Iss. 8, pp. 730-736
Closed Access | Times Cited: 2
Ryo Otani, Kazumoto Shibuya, Yoichi Suzuki, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024) Vol. 95, Iss. 8, pp. 730-736
Closed Access | Times Cited: 2
Patients’ experiences with methylcobalamin injections in amyotrophic lateral sclerosis
Adeel Zubair, Léa Saab, Kirsten Scharer, et al.
Brain Circulation (2024) Vol. 10, Iss. 1, pp. 60-66
Open Access | Times Cited: 2
Adeel Zubair, Léa Saab, Kirsten Scharer, et al.
Brain Circulation (2024) Vol. 10, Iss. 1, pp. 60-66
Open Access | Times Cited: 2
Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis
Xiaoyan Li, Richard Bedlack
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 2, pp. 93-102
Open Access | Times Cited: 2
Xiaoyan Li, Richard Bedlack
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 2, pp. 93-102
Open Access | Times Cited: 2
Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update
Léa Lescouzères, Scott B. Patten
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 10, pp. 1213-1233
Open Access | Times Cited: 2
Léa Lescouzères, Scott B. Patten
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 10, pp. 1213-1233
Open Access | Times Cited: 2
